Danner, L; Pammer, A; Kienzl, M; Ristic, D; Kaspret, D; Doyle, A; Schicho, R; Gruden, E
Cannabinoid receptor 2 is immunoprotective in models of
allergic diseases via differentiation of T regulatory cells
28th Meeting of the Austrian Pharmacological Society; SEP 23-25, 2024; Innsbruck, AUSTRIA. 2024.
[Poster]
Gruden, E; Danner, L; Petracco, G; Kienzl, M; Ristic, D; Oberdorfer, G; Reichmann, F; Schicho, R
Investigating IL-37 as a potential therapeutic option in inflammatory GI disorders
28th Meeting of the Austrian Pharmacological Society; SEP 23-25, 2024; Innsbruck, AUSTRIA. 2024.
[Poster]
Gruden, E; Kienzl, M; Schmid, ST; Sarsembayeva, A; Ristić, D; Kindler, O; Kargl, J; Doyle, A; Baumann-Durchschein, F; Konrad, J; Blesl, A; Schlager, H; Schicho R
Multicolor flow cytometric determination of immune-cell composition and activation in eosinophilic esophagitis
27th Scientific Symposium of the Austrian Pharmacological Society; SEP 29-30, 2023; Vienna. 2023.
[Poster]
Gruden, E; Kienzl, M; Schmid, ST; Sarsembayeva, A; Ristić, D; Kindler, O; Kargl, J; Doyle, A; Baumann-Durchschein, F; Konrad, J; Blesl, A; Schlager, H; Schicho R.
Analysis of Immune cell Composition and Activation in Eosinophilic Esophagitis
ÖGAI 2023 Annual Meeting; SEP 14-16, 2023; Linz. 2023.
[Poster]
Gruden, E; Kienzl, M; Schmid, ST; Sarsembayeva, A; Ristic, D; Kindler, O; Kargl, J; Doyle, A; Baumann-Durchschein, F; Konrad, J; Blesl, A; Schlager, H; Schicho, R
Multicolor Flow Cytometric Determination of Immune Cell Composition and Activation in Eosinophilic Esophagitis
12th Biennial Symposium of the International Eosinophil Society; JUL 11-15, 2023; Hamilton, CANADA. 2023.
[Poster]
Gruden, E; Pammer, A; Kienzl, M; Sarsembayeva, A; Ristic, D; Doyle, A; Baumann-Durschein, F; Konrad, J; Blesl, A; Schlager, H; Schicho R
Monoacylglycerol Lipase Inhibition In Esophageal Epithelial Cells In Pathogenesis of Eosinophilic Esophagitis
12th Biennial Symposium of the International Eosinophil Society; JUL 11-15, 2023; Hamilton Canada. 2023.
[Poster]
Kienzl, M; Herceg, K; Gruden, E; Ristic, D; Sarsembayeva, A; Maitz, K; Kargl, J; Schicho, R
Investigating the impact of eosinophils on lung cancer progression
ÖGAI 2023 Annual Meeting; SEP 14-16, 2023; Linz, AUSTRIA. 2023.
[Poster]
Ristic, D; Kienzl, M; Gruden, E; Sarsembayeva, A; Herceg, K; Kargl, J; Schicho, R
G Protein-Coupled Receptor 55 in Pancreatic Cancer: An Immunomodulatory Role.
27th Scientific Symposium of the Austrian Pharmacological Society; SEP 29-30, 2023; Vienna. 2023.
[Poster]
Ristic, D; Kienzl, M; Sarsembayeva, A; Herceg, K; Kargl, J; Schicho, R
G Protein-Coupled Receptor 55 in Pancreatic Cancer: An Immunomodulatory Role.
Annual Meeting of the Austrian Society for Allergology and Immunology (ÖGAI); SEP 14-16, 2023; Linz, Austria. 2023.
[Poster]
Gruden, E; Pammer, A; Kienzl, M; Sarsembayeva, A; Ristic, D; Baumann-Durchschein, F; Schlager, H; Schicho, R
The implications of monoacylglycerol lipase inhibition in esophageal epithelial cells for the pathogenesis of eosinophilic esophagitis
; SEP 23-24; Graz, Austria. 2022.
[Oral Communication]
Gruden, E; Pammer, A; Kienzl, M; Sarsembayeva, A; Ristic, D; Schicho, R
The role of the Cannabinoid receptor 2 (CB2) in T regulatory cell differentiation and function.
EUR J IMMUNOL. 2022; 52: 264-264.-Joint meeting DFGI & ÖGAI; SEPT 7-10, 2022; Hannover, Germany.
[Poster]
Web of Science
Kienzl, M; Gruden, E; Sarsembayeva, A; Maitz, K; Ristic, D; Valadez-Cosmes, P; Kargl, J; Schicho, R
CRTH2 as a pro-tumorigenic driver in the tumor microenvironment of experimental models of colon cancer
EUR J IMMUNOL. 2022; 52: 281-281.-Joint meeting DFGI & ÖGAI; SEPT 7-10, 2022; Hannover, Germany.
[Poster]
Web of Science
Kienzl, M; Sarsembayeva, A; Gruden, E; Ristic, D; Maitz, K; Hasenoehrl, C; Sturm, EM; Kargl, J; Schicho, R
Type 1 Activated eosinophils contribute to natural killer cell recruitment and the control of tumor growth in colorectal cancer
14th ÖGMBT Annual Meeting; SEP 19-22, 2022; Vienna. 2022.
[Poster]
Ristic, D; Kienzl, M; Sarsembayeva, A; Gruden, E; Kargl, J; Schicho, R
Pro-tumorigenic role of GPR55 in the immune microenvironment of pancreatic cancer
EUR J IMMUNOL. 2022; 52: 291-291.-Joint meeting DFGI & ÖGAI; SEPT 7-10, 2022; Hannover, Germany.
[Poster]
Web of Science
Ristic, D; Sarsembayeva, A; Kienzl, M; Gruden, E; Maitz, K; Teppan, J; Raftopoulou, S; Kindler, O; Santiso Sánchez, A; Kargl, J; Strobl, H; Schicho, R;
Role of GPR55 in the tumor microenvironment of pancreatic cancer.
DocDay Medical University of Graz; FEB 10, 2022; Graz, Austria. 2022.
[Poster]
Sarsembayeva, A; Kienzl, M; Gruden, E; Ristic, D; Brcic, L; Kargl, J; Schicho, R
The cannabinoid receptor 2 and its role in tumor progression in non-small cell lung cancer
25th Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; Sep 23-24, 2022; Graz, Austria. 2022.
[Oral Communication]
Sarsembayeva, A; Kienzl, M; Gruden, E; Ristic, D; Kargl, J; Schicho, R
Cannabinoid receptor 2 plays a pro-tumorigenic role in non-small cell lung cancer by limiting anti-tumor activity of T and NK cells
Abstract Book. 2022; -14th ÖGMBT Annual Meeting 2022, 'Life Sciences-now more than ever'; Sep 19-22, 2022; Viennca, Austria.
[Oral Communication]
Sarsembayeva, A; Kienzl, M; Gruden, E; Ristic, D; Kargl, J; Schicho, R
Cannabinoid receptor 2 creates a suppressive tumor immune microenvironment in a mouse model of lung cancer and predicts responsiveness to anti-PD-1 antibody treatment
EUR J IMMUNOL. 2022; 52: 78-79.-Joint meeting DFGI & ÖGAI; SEPT 7-10, 2022; Hannover, Germany.
[Oral Communication]
Web of Science
FullText
Ristic, D; Markovic, M; Maksimovic-Ivanic, D; Mijatovic, S;
The effects of Salinomycin on melanoma cell lines of different invasiveness
5th Congress of the Serbian Association for Cancer Research; 3.12.2021; Belgrade, Serbia. 2021.
[Onlinepräsentation]
FullText